RecruitingNCT03831126

Stress and Fetal Brain Development

The Impact of Stress on Fetal Brain Development


Sponsor

University Hospital Tuebingen

Enrollment

24 participants

Start Date

Feb 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The current proposal aims to investigate the impact of acute stress on the fetal autonomic nervous system.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • German speakers (fluently)
  • Gestational age between 28 and 34 weeks
  • Treatment with Betamethasone for improvement of fetal lung function -

Exclusion Criteria5

  • Smoking (regularly)
  • Alcohol and drug consumption during pregnancy
  • Congenital fetal disorders
  • Women with bed rest
  • acute depression or other psychiatric disorder (self report)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBetamethason Sodium Phosphate

First measurement: 12-36 hours after betamethasone treatment Second measurement: within five days after betamethasone treatment and two weeks Third measurement (neonatal measurement): 1-8 weeks after birh


Locations(1)

University Hospital Tuebingen, Department of Women's Health

Tübingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03831126


Related Trials